501 related articles for article (PubMed ID: 17786857)
1. G-protein-coupled receptor heterodimerization: assay technologies to clinical significance.
Kent T; McAlpine C; Sabetnia S; Presland J
Curr Opin Drug Discov Devel; 2007 Sep; 10(5):580-9. PubMed ID: 17786857
[TBL] [Abstract][Full Text] [Related]
2. Heterodimerization of g protein-coupled receptors: specificity and functional significance.
Prinster SC; Hague C; Hall RA
Pharmacol Rev; 2005 Sep; 57(3):289-98. PubMed ID: 16109836
[TBL] [Abstract][Full Text] [Related]
3. The structure and dynamics of GPCR oligomers: a new focus in models of cell-signaling mechanisms and drug design.
Filizola M; Weinstein H
Curr Opin Drug Discov Devel; 2005 Sep; 8(5):577-84. PubMed ID: 16159019
[TBL] [Abstract][Full Text] [Related]
4. Structural diversity of G protein-coupled receptors and significance for drug discovery.
Lagerström MC; Schiöth HB
Nat Rev Drug Discov; 2008 Apr; 7(4):339-57. PubMed ID: 18382464
[TBL] [Abstract][Full Text] [Related]
5. G protein-coupled receptor oligomerization: implications for G protein activation and cell signaling.
Breitwieser GE
Circ Res; 2004 Jan; 94(1):17-27. PubMed ID: 14715532
[TBL] [Abstract][Full Text] [Related]
6. Physiological relevance of GPCR oligomerization and its impact on drug discovery.
Panetta R; Greenwood MT
Drug Discov Today; 2008 Dec; 13(23-24):1059-66. PubMed ID: 18824244
[TBL] [Abstract][Full Text] [Related]
7. Past, present and future of vasopressin and oxytocin receptor oligomers, prototypical GPCR models to study dimerization processes.
Cottet M; Albizu L; Perkovska S; Jean-Alphonse F; Rahmeh R; Orcel H; Méjean C; Granier S; Mendre C; Mouillac B; Durroux T
Curr Opin Pharmacol; 2010 Feb; 10(1):59-66. PubMed ID: 19896898
[TBL] [Abstract][Full Text] [Related]
8. G-protein-coupled receptor-focused drug discovery using a target class platform approach.
Heilker R; Wolff M; Tautermann CS; Bieler M
Drug Discov Today; 2009 Mar; 14(5-6):231-40. PubMed ID: 19121411
[TBL] [Abstract][Full Text] [Related]
9. I want a new drug: G-protein-coupled receptors in drug development.
Schlyer S; Horuk R
Drug Discov Today; 2006 Jun; 11(11-12):481-93. PubMed ID: 16713899
[TBL] [Abstract][Full Text] [Related]
10. The future of G protein-coupled receptors as targets in drug discovery.
Lundstrom K
IDrugs; 2005 Nov; 8(11):909-13. PubMed ID: 16254784
[TBL] [Abstract][Full Text] [Related]
11. Modulating receptor function through RAMPs: can they represent drug targets in themselves?
Sexton PM; Poyner DR; Simms J; Christopoulos A; Hay DL
Drug Discov Today; 2009 Apr; 14(7-8):413-9. PubMed ID: 19150656
[TBL] [Abstract][Full Text] [Related]
12. Dimerization and oligomerization of G-protein-coupled receptors: debated structures with established and emerging functions.
Szidonya L; Cserzo M; Hunyady L
J Endocrinol; 2008 Mar; 196(3):435-53. PubMed ID: 18310440
[TBL] [Abstract][Full Text] [Related]
13. The 7 TM G-protein-coupled receptor target family.
Jacoby E; Bouhelal R; Gerspacher M; Seuwen K
ChemMedChem; 2006 Aug; 1(8):761-82. PubMed ID: 16902930
[TBL] [Abstract][Full Text] [Related]
14. G-protein-coupled receptor oligomerization and its potential for drug discovery.
George SR; O'Dowd BF; Lee SP
Nat Rev Drug Discov; 2002 Oct; 1(10):808-20. PubMed ID: 12360258
[TBL] [Abstract][Full Text] [Related]
15. The study of G-protein coupled receptor oligomerization with computational modeling and bioinformatics.
Filizola M; Weinstein H
FEBS J; 2005 Jun; 272(12):2926-38. PubMed ID: 15955053
[TBL] [Abstract][Full Text] [Related]
16. From purified GPCRs to drug discovery: the promise of protein-based methodologies.
Alkhalfioui F; Magnin T; Wagner R
Curr Opin Pharmacol; 2009 Oct; 9(5):629-35. PubMed ID: 19443270
[TBL] [Abstract][Full Text] [Related]
17. Allosteric properties of G protein-coupled receptor oligomers.
Springael JY; Urizar E; Costagliola S; Vassart G; Parmentier M
Pharmacol Ther; 2007 Sep; 115(3):410-8. PubMed ID: 17655934
[TBL] [Abstract][Full Text] [Related]
18. Technology Insight: modern methods to monitor protein-protein interactions reveal functional TSH receptor oligomerization.
Persani L; Calebiro D; Bonomi M
Nat Clin Pract Endocrinol Metab; 2007 Feb; 3(2):180-90. PubMed ID: 17237844
[TBL] [Abstract][Full Text] [Related]
19. GPCR-GIP networks: a first step in the discovery of new therapeutic drugs?
Bockaert J; Dumuis A; Fagni L; Marin P
Curr Opin Drug Discov Devel; 2004 Sep; 7(5):649-57. PubMed ID: 15503867
[TBL] [Abstract][Full Text] [Related]
20. Allosteric ligands for G protein-coupled receptors: a novel strategy with attractive therapeutic opportunities.
De Amici M; Dallanoce C; Holzgrabe U; Tränkle C; Mohr K
Med Res Rev; 2010 May; 30(3):463-549. PubMed ID: 19557759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
